Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
Primary Purpose
Type 2 Diabetes Mellitus, Healthy, Overweight
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cardiovascular exercise training
Sponsored by

About this trial
This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring Type 2 Diabetes, Overweight, Exercise Training, Exercise Impairment, Healthy Control, Veteran, Blood Flow
Eligibility Criteria
Inclusion Criteria:
- Men and women with and without type 2 diabetes
- BMI 25-40
- Sedentary subjects not participating in a regular exercise program (<one bout of exercise/week)
Exclusion Criteria:
- Documented cardiovascular disease
- Uncontrolled hypertension: disease systolic blood pressure (SBP) > 150, diastolic blood pressure (DBP)> 110
- Obstructive pulmonary disease or asthma
- Peripheral neuropathy
- Physical impairment that would limit exercise ability
- Subjects taking beta blockers, calcium channel blockers, insulin, or Thiazolidinediones (TZD)
- Current or past smoking within the last 1 years
- Current tobacco use
- Anemia
- Control HbA1c > 5.7, T2DM HbA1c > 9
- Pregnant, nursing or hormonal therapy (other than contraceptives)
- Peri or post-menopausal women
- Type 1 diabetes
- Hepatic or renal disease.
- Peptic ulcer disease.
Sites / Locations
- University of Colorado, Anschutz Medical Campus
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Type 2 diabetes
Healthy overweight controls
Arm Description
Men and women between the ages of 30-55 with well controlled type 2 diabetes (A1C <9%).
Men and women between the ages of 30-55 with BMI 25-40 and limited immediate family history of type 2 diabetes.
Outcomes
Primary Outcome Measures
Change in peak oxygen consumption (VO2peak)
Subjects' peak oxygen consumption will be tested on a stationary bike before and after 3 months of exercise
Change in insulin sensitivity
The investigators will evaluate the changes in insulin sensitivity utilizing a euglycemic insulin clamp
Change in muscular mitochondrial function
The investigators will examine mitochondrial function using magnetic resistance (MR) spectroscopy during single leg calf exercise
Secondary Outcome Measures
Full Information
NCT ID
NCT03419195
First Posted
January 18, 2018
Last Updated
July 10, 2023
Sponsor
University of Colorado, Denver
Collaborators
VA Eastern Colorado Health Care System
1. Study Identification
Unique Protocol Identification Number
NCT03419195
Brief Title
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
Official Title
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
February 7, 2018 (Actual)
Primary Completion Date
March 20, 2023 (Actual)
Study Completion Date
March 20, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Colorado, Denver
Collaborators
VA Eastern Colorado Health Care System
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This study will define the relationship of cardiac, vascular function and skeletal muscle blood flow (individually and together) to cardiovascular exercise capacity in in men and women with and without type 2 diabetes (T2DM). Identification of differences in the effects of exercise training on the integrated cardiovascular system and metabolism in men and women with and without T2DM will reveal specific adaptive responses to exercise.This study will evaluate & compare exercise function in a total of 60 subjects from the Denver area (30 people with T2DM and 30 overweight control subjects).
Specific Aim 1: To test the hypothesis that the integration of cardiac function, macrovascular function, and microvascular function is impaired in T2D and correlates with cardiovascular exercise capacity (CVEC) impairment.
Specific Aim 2: To test the hypothesis that exercise training will elicit adaptive responses in cardiac and vascular function, muscle perfusion and metabolism with differences by T2D status.
Differences between the exercise responses in people with T2DM and healthy people will help further identify the disease process of T2DM and direct future research of treatments and interventions.
Detailed Description
It is well established that functional exercise capacity and peak oxygen uptake (VO2) are reduced in patients with type 2 diabetes mellitus (T2DM) compared with healthy counterparts. The mechanisms underlying the exercise deficit in T2DM remain largely unknown, but previous work has suggested that reduced exercise blood flow and impaired submaximal VO2 may be contributing factors. Both of these findings are consistent with a peripheral impairment of skeletal muscle oxygen delivery, oxygen utilization, or both. Indeed, dysfunction of skeletal muscle metabolism plays a key role in the pathophysiology of T2DM, and considerable work has described abnormalities of oxidative function in the skeletal muscle of people with T2DM. Given this, it is likely that the causes of exercise intolerance in T2DM may relate to specific defects at the level of the skeletal muscle, particularly given that skeletal muscle blood flow and oxidative capacity are impaired in diabetes. However, to the knowledge of the investigators, no one has related these peripheral muscle abnormalities to the diminished exercise function in this patient group.
The overarching hypothesis for the proposed research is that impaired CVEC in T2DM is the result of preclinical cardiac, vascular dysfunction and skeletal muscle perfusion abnormalities. Exercise training will improve CVEC and will reveal specific reversible therapeutic aspects of this pathology. The investigators will first determine the impairments and then evaluate responses to an established cardiac rehabilitation exercise training program, established to improve fitness in people with and without diabetes. Given the greater CVEC abnormalities observed in women, sex differences will be evaluated for each aim.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus, Healthy, Overweight, Cardiovascular Risk Factor
Keywords
Type 2 Diabetes, Overweight, Exercise Training, Exercise Impairment, Healthy Control, Veteran, Blood Flow
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
124 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Type 2 diabetes
Arm Type
Experimental
Arm Description
Men and women between the ages of 30-55 with well controlled type 2 diabetes (A1C <9%).
Arm Title
Healthy overweight controls
Arm Type
Experimental
Arm Description
Men and women between the ages of 30-55 with BMI 25-40 and limited immediate family history of type 2 diabetes.
Intervention Type
Other
Intervention Name(s)
Cardiovascular exercise training
Other Intervention Name(s)
Exercise Training
Intervention Description
Following the completion of baseline testing, both subject groups will undergo supervised cardiovascular exercise training 3 times per week for 3 months (plus a 3 week ramp-up). Exercise training will take place on a treadmill, stationary bicycle, elliptical, rowing machine, or combination of machines. Each session will last 1 hour, which includes a 5 minute warm-up, 50 minutes of exercise, and a 5 minute cool down.
Primary Outcome Measure Information:
Title
Change in peak oxygen consumption (VO2peak)
Description
Subjects' peak oxygen consumption will be tested on a stationary bike before and after 3 months of exercise
Time Frame
Through study completion, approximately 4 months
Title
Change in insulin sensitivity
Description
The investigators will evaluate the changes in insulin sensitivity utilizing a euglycemic insulin clamp
Time Frame
Through study completion, approximately 4 months
Title
Change in muscular mitochondrial function
Description
The investigators will examine mitochondrial function using magnetic resistance (MR) spectroscopy during single leg calf exercise
Time Frame
Through study completion, approximately 4 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Men and women with and without type 2 diabetes
BMI 25-40
Sedentary subjects not participating in a regular exercise program (<one bout of exercise/week)
Exclusion Criteria:
Documented cardiovascular disease
Uncontrolled hypertension: disease systolic blood pressure (SBP) > 150, diastolic blood pressure (DBP)> 110
Obstructive pulmonary disease or asthma
Peripheral neuropathy
Physical impairment that would limit exercise ability
Subjects taking beta blockers, calcium channel blockers, insulin, or Thiazolidinediones (TZD)
Current or past smoking within the last 1 years
Current tobacco use
Anemia
Control HbA1c > 5.7, T2DM HbA1c > 9
Pregnant, nursing or hormonal therapy (other than contraceptives)
Peri or post-menopausal women
Type 1 diabetes
Hepatic or renal disease.
Peptic ulcer disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Judy Regensteiner, PhD
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Colorado, Anschutz Medical Campus
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
We'll reach out to this number within 24 hrs